Skip to main content
Premium Trial:

Request an Annual Quote

California Clears Decode Genetics' Clinical Lab

NEW YORK (GenomeWeb News) — The State of California has cleared Decode Genetics to market its genotyping tests to the state’s physicians and residents by giving the company a clinical laboratory license, Decode said today.

The state had forbidden Decode and a number of other firms from offering genetic tests directly to consumers last summer. At the time, California officials said that these companies were not in compliance with state law governing lab compliance and certification and that there were concerns about physician oversight of the services.

Decode CEO Kari Stefansson said in a statement today that the company is unique in that it discovers genetic risk factors for common diseases and brings to market reference lab tests and DTC scans. "Our competitors outsource the science, the DNA-analysis, or both," he said. "But for us this is the real foundation of personalized medicine."

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.